Scenarios that move UTHR
United Therapeutics Corporation - Common Stock
Scenarios that move UTHR: 4 analyses, 4 positive, 0 negative.
- · Syndax stock falls 16% as Phase II fibrosis study misses primary goal — ▲ · impact +18 · confidence high · horizon immediate
- · Liquidia stock plunges 57% after UTHR patent setback — ▲ · impact +85 · confidence high · horizon immediate
- · United Therapeutics stock rises 12.6% in trading — ▲ · impact +91 · confidence medium · horizon immediate
- · Ascendis announces planned $400 million share repurchase program — ▲ · impact +10 · confidence low · horizon quarters